Treatment after Immune checkpoint inhibition: Impact on biology?
Guillermo de Velasco MD, PhD, presents Treatment after Immune checkpoint inhibition: Impact on biology? at the International Kidney Cancer Symposium 2018.<br />
Author: kidneycancer
Added: 05/03/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 3, 2018 Category: Cancer & Oncology Source Type: podcasts
Treatment after immune checkpoint in first/second line setting: Clinical perspective
Laurence Albiges, MD, PhD, presents Treatment after immune checkpoint in first/second line setting: Clinical perspective at the International Kidney Cancer Symposium 2018
Author: kidneycancer
Added: 05/03/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 3, 2018 Category: Cancer & Oncology Source Type: podcasts
Minimally invasive partial nephrectomy is NOT a cause of seeding of RCC
Ravi Barod PhD FRCS (Urol) presents Minimally invasive partial nephrectomy is NOT a cause of seeding of RCC at the International Kidney Cancer Symposium. <br />
Author: kidneycancer
Added: 05/03/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 3, 2018 Category: Cancer & Oncology Source Type: podcasts
DEBATE: Cancer Seeding and Minimally Invasive Kidney Tumor Surgery
Paul Russo, MD, FACS, presents DEBATE: Cancer Seeding and Minimally Invasive Kidney Tumor Surgery at the International Kidney Cancer Symposium 2018
Author: kidneycancer
Added: 05/03/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 3, 2018 Category: Cancer & Oncology Source Type: podcasts
New Generation of Biomarkers for IO: Fact or Fiction?
Sumanta Kumar Pal, M.D. Associate Professor, Department of Medical Oncology & Therapeutics Research Co-Director, Kidney Cancer Program City of Hope Comprehensive Cancer Center discusses the New Genera...
Author: kidneycancer
Added: 04/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 29, 2018 Category: Cancer & Oncology Source Type: podcasts
VEGF + I/O combinations in Renal Cell Carcinoma
Brian I. Rini, MD, Cleveland Clinic discusses VEGF + I/O combinations in Renal Cell Carcinoma at the 13th European International Kidney Cancer Symposium 2018 in Prague.<br />
Author: kidneycancer
Added: 04/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 29, 2018 Category: Cancer & Oncology Source Type: podcasts
Debate: PRO IO/IO in 1st Line
Hans Hammers, MD, PhD, Associate Professor, UT Southwestern takes the pro stance during a debate on IO/IO in 1st Line at the 13th European International Kidney Cancer Symposium 2018 in Prague.<br />
Author: kidneycancer
Added: 04/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 29, 2018 Category: Cancer & Oncology Source Type: podcasts
Tracking the evolution of renal cell carcinoma: TRACERx Renal
Samra Turajlic, Consultant Medical Oncologist, The Royal Marsden NHS Foundation Trust <br />CRUK Clinician Scientist, The Francis Crick Institute discusses Tracking the evolution of renal cell carcinoma: ...
Author: kidneycancer
Added: 04/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 29, 2018 Category: Cancer & Oncology Source Type: podcasts
Immunotherapy: The Role of the Microbiome
Dr. Lisa Derosa, MD, PhD Candidate Immunoncology - Pr. L. Zitvogel discusses The Role of the Microbiome in Immunotherapy at the 13th European International Kidney Cancer Symposium 2018 in Prague.<br /><br />
Author: kidneycancer
Added: 04/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 29, 2018 Category: Cancer & Oncology Source Type: podcasts
The neo-antigen landscape in renal cell carcinoma
Samra Turajlic, Consultant Medical Oncologist, The Royal Marsden NHS Foundation Trust CRUK Clinician Scientist, The Francis Crick Institute discusses the neo-antigen landscape in renal cell carcinoma ...
Author: kidneycancer
Added: 04/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 28, 2018 Category: Cancer & Oncology Source Type: podcasts
Immunotherapy: Bridging Knowledge from Melanoma
Dr James Larkin, Consultant Medical Oncologist at The Royal Marsden NHS Foundation Trust discusses "Immunotherapy: Bridging Knowledge from Melanoma" from a Kidney Cancer point of view at the 13th Eur...
Author: kidneycancer
Added: 04/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 28, 2018 Category: Cancer & Oncology Source Type: podcasts
Patient Expectations of Adjuvant Therapy in Kidney Cancer
Tim Eisen, University of Cambridge discusses Patient Expectations of Adjuvant Therapy in Kidney Cancer at the 13th European International Kidney Cancer Symposium 2018 in Prague.
Author: kidneycancer
Added: 04/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 28, 2018 Category: Cancer & Oncology Source Type: podcasts
Biologic Rational For Neoadjuvant OVER Adjuvant Approach with IO
Lauren Harshman MD, Co-director of Kidney Cancer Program Dana-Farber Cancer Institute/Harvard Medical School discusses Biologic Rational For Neoadjuvant OVER Adjuvant Approach with IO at the 13th Euro...
Author: kidneycancer
Added: 04/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 28, 2018 Category: Cancer & Oncology Source Type: podcasts
Debate: No Adjuvant Therapy Kidney Cancer
Axel Bex, The Netherlands Cancer Institute Amsterdam debates the side of No Adjuvant Therapy Kidney Cancer at the 13th European International Kidney Cancer Symposium 2018 in Prague.<br />
Author: kidneycancer
Added: 04/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 28, 2018 Category: Cancer & Oncology Source Type: podcasts
Yes for Adjuvant Therapy with Full Dose VEGFR TKI
Michael Staehler, Ludwig-Maximilians-University of Munich | LMU discusses Yes for Adjuvant Therapy with Full Dose VEGFR TKI at the 13th European International Kidney Cancer Symposium 2018 in Prague...
Author: kidneycancer
Added: 04/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 28, 2018 Category: Cancer & Oncology Source Type: podcasts
